Review article: the future of microbiome-based therapeutics.

"Declaration of funding interests: This work is supported by an ARC Discovery Project (DP190101504 to SCF) and the Victorian Government's Operational Infrastructure Support Program. Declaration of personal interests: SPC has received speaker fees from Shire, Ferring, Microbiotica, Pfizer and Janssen and is a shareholder in BiomeBank. RVB has received grant/research support and/or speaker fees [all paid to employer for research support] from AbbVie, Ferring, Janssen, Shire, Takeda and Emerge Health. Open access publishing facilitated by University of Otago, as part of the Wiley ‐ University of Otago agreement via the Council of Australian University Librarians."

"Declaration of funding interests:This work is supported by an ARC Discovery Project (DP190101504 to SCF) and the Victorian Government's Operational Infrastructure Support Program."